Loading stock data…
Treace Medical Concepts, Inc. (TMCI)
$4.63-0.18 (-3.74%)
Market ClosedLast close Sep 8
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Treace Medical Concepts, Inc. in the Healthcare sector is trading at $4.63 with a market capitalization of $315M. Wall Street consensus targets $5.50 (3 analysts), implying a +18.8% move over the next 12 months. The stock is currently 39% below its 52-week high of $7.61, remaining 58.6% above its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +18.8% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $47.20M↓ | $62.52M↑ | $50.21M↑ | $47.39M↓ | $52.57M |
| Gross Profit | $37.41M↓ | $50.40M↑ | $39.71M↑ | $37.75M↓ | $41.89M |
| Operating Income | -$17.17M↓ | -$5.92M↑ | -$15.68M↑ | -$16.97M↓ | -$15.58M |
| Net Income | -$17.96M↓ | -$9.39M↑ | -$16.29M↑ | -$17.40M↓ | -$15.92M |
Peer Comparison
JNJUNHPFE
Fundamentals
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stab...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$314.77M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.40
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-87.86%
Volume
Today's trading volume
267,916
Recent News
Treace Medical (TMCI) Q2 2026 Earnings Call Transcript
Surgeon adoption of new bunion systems drove accelerating case volume growth.
Treace Medical Concepts, Inc. Q2 2026 Earnings Call Summary
Moby summary of Treace Medical Concepts, Inc.'s Q2 2026 earnings call
Treace Medical Concepts Inc (TMCI) (Q2 2026) Earnings Call Highlights: Revenue Declines 4% but ...
Despite a 4% year-over-year revenue dip, Treace Medical Concepts Inc (TMCI) narrows its adjusted EBITDA loss and raises full-year guidance on strong adoption of new bunion systems.
Treace Medical Concepts Q2 Earnings Call Highlights
Treace Medical Concepts (NASDAQ:TMCI) reported second-quarter 2026 revenue of $45.4 million, down 4% from the prior-year period, as lower procedure-kit sales to stocking distributors and a continued shift toward lower-priced minimally invasive products weighed on reported sales. Chief Executive Off
Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates
Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of +20.00% and +3.42%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?